| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
|
J Natl Cancer Inst
|
2008
|
5.09
|
|
2
|
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.
|
J Clin Oncol
|
2010
|
3.76
|
|
3
|
Using relative utility curves to evaluate risk prediction.
|
J R Stat Soc Ser A Stat Soc
|
2009
|
3.04
|
|
4
|
Acupuncture for migraine prophylaxis.
|
Cochrane Database Syst Rev
|
2009
|
3.00
|
|
5
|
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.
|
BMJ
|
2014
|
2.61
|
|
6
|
Acupuncture for tension-type headache.
|
Cochrane Database Syst Rev
|
2009
|
2.47
|
|
7
|
Complications after radical and partial nephrectomy as a function of age.
|
J Urol
|
2010
|
2.36
|
|
8
|
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.
|
J Clin Oncol
|
2012
|
2.28
|
|
9
|
Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
|
Eur Urol
|
2011
|
2.22
|
|
10
|
Prostate cancer mortality in areas with high and low prostate cancer incidence.
|
J Natl Cancer Inst
|
2014
|
2.16
|
|
11
|
Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.
|
J Urol
|
2010
|
1.91
|
|
12
|
Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.
|
J Clin Oncol
|
2007
|
1.88
|
|
13
|
Contemporary use of partial nephrectomy at a tertiary care center in the United States.
|
J Urol
|
2009
|
1.78
|
|
14
|
Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.
|
Eur Urol
|
2013
|
1.73
|
|
15
|
Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer.
|
Eur Urol
|
2006
|
1.67
|
|
16
|
Timing of curative treatment for prostate cancer: a systematic review.
|
Eur Urol
|
2013
|
1.63
|
|
17
|
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan.
|
Leuk Res
|
2005
|
1.59
|
|
18
|
Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy.
|
Eur Urol
|
2006
|
1.50
|
|
19
|
Randomized controlled trial of a special acupuncture technique for pain after thoracotomy.
|
J Thorac Cardiovasc Surg
|
2008
|
1.49
|
|
20
|
Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents.
|
BMC Med Res Methodol
|
2012
|
1.47
|
|
21
|
Acupuncture for the prevention of episodic migraine.
|
Cochrane Database Syst Rev
|
2016
|
1.47
|
|
22
|
Acupuncture for the prevention of tension-type headache.
|
Cochrane Database Syst Rev
|
2016
|
1.46
|
|
23
|
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005.
|
J Urol
|
2008
|
1.43
|
|
24
|
[Does use of alternative medicine aggravate the survival prognosis in cancer?].
|
Tidsskr Nor Laegeforen
|
2003
|
1.40
|
|
25
|
Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting.
|
J Clin Oncol
|
2005
|
1.32
|
|
26
|
The learning curve for laparoscopic radical prostatectomy: an international multicenter study.
|
J Urol
|
2010
|
1.30
|
|
27
|
A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making.
|
BMC Med Inform Decis Mak
|
2010
|
1.23
|
|
28
|
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
|
Cancer Immunol Immunother
|
2002
|
1.22
|
|
29
|
Integrative Oncology Practice Guidelines.
|
J Soc Integr Oncol
|
2007
|
1.21
|
|
30
|
Multimorbidity and evidence generation.
|
J Gen Intern Med
|
2014
|
1.17
|
|
31
|
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
|
J Urol
|
2006
|
1.17
|
|
32
|
Treating metastatic disease: Which survival model is best suited for the clinic?
|
Clin Orthop Relat Res
|
2013
|
1.17
|
|
33
|
Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer.
|
ScientificWorldJournal
|
2007
|
1.12
|
|
34
|
Statistical consideration for clinical biomarker research in bladder cancer.
|
Urol Oncol
|
2010
|
1.12
|
|
35
|
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
|
Int J Cancer
|
2007
|
1.09
|
|
36
|
Four-hundredfold overestimation of biopsy mortality.
|
BJU Int
|
2013
|
1.07
|
|
37
|
Re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87: statistical concerns with Briganti radiotherapy analysis.
|
Eur Urol
|
2013
|
1.06
|
|
38
|
The status and future of acupuncture clinical research.
|
J Altern Complement Med
|
2008
|
1.06
|
|
39
|
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.
|
Stat Med
|
2014
|
1.03
|
|
40
|
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France.
|
BMC Cancer
|
2010
|
1.03
|
|
41
|
Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.
|
Curr Opin Urol
|
2016
|
1.00
|
|
42
|
Prediction models in urology: are they any good, and how would we know anyway?
|
Eur Urol
|
2009
|
0.96
|
|
43
|
Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer.
|
Int J Urol
|
2007
|
0.94
|
|
44
|
Evaluation of widely consumed botanicals as immunological adjuvants.
|
Vaccine
|
2008
|
0.94
|
|
45
|
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer.
|
Cancer
|
2006
|
0.93
|
|
46
|
Natural history of positive urinary cytology after radical cystectomy.
|
J Urol
|
2006
|
0.93
|
|
47
|
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma.
|
J Mol Diagn
|
2007
|
0.93
|
|
48
|
Gleason 6 Prostate Cancer: Translating Biology into Population Health.
|
J Urol
|
2015
|
0.91
|
|
49
|
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients.
|
Cancer Chemother Pharmacol
|
2009
|
0.91
|
|
50
|
Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma.
|
Int J Cancer
|
2006
|
0.89
|
|
51
|
A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients.
|
J Ethnopharmacol
|
2011
|
0.88
|
|
52
|
Evaluation of prediction models for decision-making: beyond calibration and discrimination.
|
PLoS Med
|
2013
|
0.87
|
|
53
|
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.
|
J Urol
|
2006
|
0.83
|
|
54
|
What has to happen before we report radical prostatectomy outcomes of individual surgeons to the public?
|
Urol Oncol
|
2010
|
0.83
|
|
55
|
Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials.
|
J Steroid Biochem Mol Biol
|
2005
|
0.83
|
|
56
|
Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.
|
Eur Urol
|
2006
|
0.82
|
|
57
|
Placebo in acupuncture trials.
|
Pain
|
2004
|
0.82
|
|
58
|
Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial.
|
Support Care Cancer
|
2013
|
0.80
|
|
59
|
How many lymphadenectomies does it take to cure one patient?
|
Eur Urol
|
2007
|
0.80
|
|
60
|
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma.
|
Oncoimmunology
|
2013
|
0.80
|
|
61
|
A phase II, randomized, controlled trial of acupuncture for reduction of Postcolectomy Ileus.
|
Ann Surg Oncol
|
2012
|
0.80
|
|
62
|
Spotlight on prostate cancer: the latest evidence and current controversies.
|
BMC Med
|
2015
|
0.79
|
|
63
|
Positive surgical margins and accessory pudendal artery preservation during laparoscopic radical prostatectomy.
|
Eur Urol
|
2005
|
0.78
|
|
64
|
Perioperative clinical thromboembolic events after radical or partial nephrectomy.
|
Urology
|
2006
|
0.78
|
|
65
|
WITHDRAWN: Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting.
|
Cochrane Database Syst Rev
|
2014
|
0.78
|
|
66
|
Novel approaches to improve prostate cancer diagnosis and management in early-stage disease.
|
BJU Int
|
2012
|
0.78
|
|
67
|
Five genetic variants associated with prostate cancer.
|
N Engl J Med
|
2008
|
0.77
|
|
68
|
Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer.
|
J Clin Oncol
|
2007
|
0.77
|
|
69
|
Acupuncture: integration into cancer care.
|
J Soc Integr Oncol
|
2006
|
0.77
|
|
70
|
Evaluation of specific and non-specific effects in homeopathy: feasibility study for a randomised trial.
|
Homeopathy
|
2006
|
0.76
|
|
71
|
Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies.
|
Integr Cancer Ther
|
2004
|
0.75
|
|
72
|
Widespread body pain and mortality. Theories that psychological states cause cancer should be rejected.
|
BMJ
|
2002
|
0.75
|
|
73
|
Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.
|
BMC Urol
|
2014
|
0.75
|
|
74
|
Acupuncture for migraine prophylaxis.
|
Sao Paulo Med J
|
2015
|
0.75
|
|
75
|
What do we mean by "outcome can be predicted"?
|
Am Heart J
|
2008
|
0.75
|
|
76
|
Recent review of research on a technique for treating cancer.
|
Integr Cancer Ther
|
2004
|
0.75
|
|
77
|
Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
|
Eur Urol
|
2013
|
0.75
|
|
78
|
Editorial comment.
|
Urology
|
2011
|
0.75
|
|
79
|
Screening for prostate cancer.
|
Ann Intern Med
|
2012
|
0.75
|
|
80
|
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?
|
Nat Rev Clin Oncol
|
2017
|
0.75
|